KCNC2

Chr 12AD

potassium voltage-gated channel subfamily C member 2

Also known as: DEE103, KV3.2

The Shaker gene family of Drosophila encodes components of voltage-gated potassium channels and is comprised of four subfamilies. Based on sequence similarity, this gene is similar to one of these subfamilies, namely the Shaw subfamily. The protein encoded by this gene belongs to the delayed rectifier class of channel proteins and is an integral membrane protein that mediates the voltage-dependent potassium ion permeability of excitable membranes. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 0.531 OMIM phenotype
Clinical SummaryKCNC2
🧬
Gene-Disease Validity (ClinGen)
genetic developmental and epileptic encephalopathy · ADDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.25) despite low pLI — interpret in context.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 123 VUS of 158 total submissions
📖
GeneReview available — KCNC2
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.53LOEUF
pLI 0.189
Z-score 3.07
OE 0.25 (0.130.53)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.98Z-score
OE missense 0.56 (0.500.63)
204 obs / 363.7 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.25 (0.130.53)
00.351.4
Missense OE?0.56 (0.500.63)
00.61.4
Synonymous OE?1.20
01.21.6
LoF obs/exp: 5 / 19.7Missense obs/exp: 204 / 363.7Syn Z: -2.01

This gene — mechanism propensity

DN
0.79top 25%
GOF
0.85top 5%
LOF
0.3454th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median · 1 literature citation · 100% of P/LP are missense
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Literature Evidence

GOFFunctional analysis of 4 variants demonstrated gain of function in 3 severely affected DEE cases and loss of function in 1 case with a milder phenotype (GGE) as the underlying pathomechanisms.DISCUSSION: These findings implicate KCNC2 as a novel causative gene for epilepsy and emphasize the critical1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 35314505

ClinVar Variant Classifications

158 submitted variants in ClinVar

Classification Summary

Pathogenic8
Likely Pathogenic9
VUS123
Likely Benign12
Benign3
Conflicting1
8
Pathogenic
9
Likely Pathogenic
123
VUS
12
Likely Benign
3
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
8
0
0
8
Likely Pathogenic
0
9
0
0
9
VUS
7
115
1
0
123
Likely Benign
0
4
1
7
12
Benign
0
0
0
3
3
Conflicting
1
Total7136210156

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

11 pathogenic / likely-pathogenic (of 23) ClinVar copy-number / structural variants overlap KCNC2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

KCNC2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →